Ishita Drugs and Industries Limited (BOM:524400)

India flag India · Delayed Price · Currency is INR
67.60
-4.30 (-5.98%)
At close: Mar 6, 2026
Market Cap202.14M -17.5%
Revenue (ttm)161.68M +8.3%
Net Income8.89M +3.1%
EPS2.97 +3.1%
Shares Out2.99M
PE Ratio22.76
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume101
Average Volume1,033
Open68.00
Previous Close71.90
Day's Range67.60 - 68.00
52-Week Range66.00 - 90.85
Beta-0.58
RSI42.10
Earnings DateFeb 7, 2026

About BOM:524400

Ishita Drugs and Industries Limited manufactures and sells active pharma ingredients (APIs), fine chemicals, drug intermediates, and excipients in India and internationally. The company offers APIs, such as sulfa drugs/sulfonamides, vitamins, fluoro quinolones, antibiotics, anthelmintics, iodides and citrates, food additives/excipients, and others. It also provides contract manufacturing services for various drug intermediates, fine chemicals, or specialty chemicals. Ishita Drugs and Industries Limited was incorporated in 1992 and is based in A... [Read more]

Industry Medicinal Chemicals and Botanical Products
Founded 1992
Employees 14
Stock Exchange Bombay Stock Exchange
Ticker Symbol 524400
Full Company Profile

Financial Performance

In fiscal year 2025, BOM:524400's revenue was 149.97 million, a decrease of -1.25% compared to the previous year's 151.88 million. Earnings were 8.68 million, an increase of 15.98%.

Financial Statements